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open surgical repair of abdominal aortic aneurysms for patients at a high
surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada
Jean-Eric Tarride, Gord Blackhouse, Guy De Rose, Teresa Novick, James M.
Bowen, Robert Hopkins, Daria O’Reilly, Ron Goeree
Background: Abdominal aortic aneurysm (AAA) is a prevalent health condi-
tion affecting up to 14% of men and 6% of women. The objective of this study
was to estimate the cost-effectiveness and cost-utility of elective endovas-
cular aneurysm repair (EVAR) compared with open surgical repair (OSR) in
patients at a high risk of surgical complications.
Methods: Patient-level cost and outcome data from a 1-year prospective
observational study conducted at London Health Sciences Centre, London,
Ontario, Canada, was used to determine the incremental cost per life-year
gained and the incremental cost per quality-adjusted life year (QALY) gained
of EVAR compared with OSR in patients with an AAA >5.5 cm and a high risk
of surgical complications. The analysis was taken from a societal perspective
and the time horizon was 1 year. To measure sampling uncertainty on costs
and effects, nonparametric bootstrap techniques were applied. Uncertainty
results were expressed using cost-effectiveness acceptability curves.
Extrapolations of the 1-year results to a 5-year time horizon were conducted
in sensitivity analyses.
Results: Between August 11, 2003, and April 3, 2005, 192 patients at a high
risk of surgical complications were enrolled: 140 received EVAR and 52 OSR.
Point estimates during a 1-year period showed that EVAR dominated OSR for
high-risk patients in terms of incremental cost per life-year gained and
incremental cost per QALYs. However, bootstrap estimates for the two
cost-effectiveness measures indicated there was a great deal of uncertainty
regarding the costs and the QALYs and less uncertainty regarding life-years
gained. If society was willing to pay $50,000 per life-year gained or per QALY
gained, the probability of EVAR being cost-effective was found to be 0.76
and 0.55, respectively. Five-year extrapolations indicated that EVAR was
cost-effective compared with OSR.
Conclusions: According to this 1-year observational study, EVAR may be
a cost-effective strategy compared with OSR for high-risk patients.
Longer-term data are needed to decrease the uncertainty associated with
the results.
Strategies to improve spinal cord ischemia in endovascular thoracic aortic
repair: Outcomes of a prospective cerebrospinal fluid drainage protocol
Jeffrey C. Hnath, Manish Mehta, John B. Taggert, Yaron Sternbach, Sean P.
Roddy, Paul B. Kreienberg, Kathleen J. Ozsvath, Benjamin B. Chang,
Dhiraj M. Shah, R. Clement Darling III
Purpose: Although endovascular repair of thoracic aortic aneurysm has been
shown to reduce the morbidity and mortality rates, spinal cord ischemia
remains a persistent problem. We evaluated our experience with spinal cord
protective measures using a standardized cerebrospinal fluid (CSF) drainage
protocol in patients undergoing endovascular thoracic aortic repair.
Methods: From 2004 to 2006, 121 patients underwent elective (n = 52, 43%)
and emergent (n = 69, 57%) endovascular thoracic aortic stent graft place-
ment for thoracic aortic aneurysm (TAA) (n = 94, 78%), symptomatic* Full articles available online at www.jvascsurg.org
1078e5884/$34.00
doi:10.1016/S1078-5884(08)00449-8penetrating ulceration (n = 11, 9%), pseudoaneurysms (n = 5, 4%) and trau-
matic aortic transactions (n = 11, 9%). In 2005, routine use of a CSF drainage
protocol was established to minimize the risks of spinal cord ischemia. The
CSF was actively drained to maintain pressures <15 mm Hg and the mean
arterial blood pressures were maintained at 90 mm Hg. Data was prospec-
tively collected in our vascular registry for elective and emergent endovas-
cular thoracic aortic repair and the patients were divided into 2 groups (+CSF
drainage protocol, CSF drainage protocol). A c2 statistical analysis was
performed and significance was assumed for P < .05.
Results: Of the 121 patients with thoracic stent graft placement, the mean
age was 72 years, 62 (51%) were male, and 56 (46%) underwent preoperative
placement of a CSF drain, while 65 (54%) did not. Both groups had similar co-
morbidities of coronary artery disease (24 [43%] vs 27 [41%]), hypertension
(44 [79%] vs 50 [77%]), chronic obstructive pulmonary disease (18 [32%] vs
22 [34%]), and chronic renal insufficiency (10 [17%] vs 12 [18%]). None of
the patients with CSF drainage developed spinal cord ischemia (SCI), and
5 (8%) of the patients without CSF drainage developed SCI within 24 hours
of endovascular repair (P< .05). All patients with clinical symptoms of SCI
had CSF drain placement and augmentation of systemic blood pressures to
90 mm Hg, and 60% (3 of 5 patients) demonstrated marked clinical
improvement.
Conclusion: Perioperative CSF drainage with augmentation of systemic
blood pressures may have a beneficial role in reducing the risk of paraplegia
in patients undergoing endovascular thoracic aortic stent graft placement.
However, selective CSF drainage may offer the same benefit as mandatory
drainage.Outcomes of surgical management for popliteal artery aneurysms: An
analysis of 583 cases
Owen N. Johnson III, Mark B. Slidell, Robyn A. Macsata, Byron J. Faler,
Richard L. Amdur, Anton N. Sidawy
Background: This study aimed to analyze outcomes of surgical management
for popliteal artery aneurysms (PAA).
Methods: This is a retrospective analysis of prospectively collected data
regarding operations for PAA obtained from 123 United States Veterans
Affairs Medical Centers as part of the National Surgical Quality Improvement
Program. Univariate analyses and multivariate logistic regression were used
to characterize 33 risk factors and their associations with 30-day morbidity
and mortality. Survival and amputation rates, observed at one and two years
after surgery, were subject to life-table and Cox regression analyses.
Results: There were 583 operations for PAA in 537 patients during 1994e
2005. Almost all were in men (99.8%) and median age was 69 years (range,
34 to 92 years). Most had multiple co-morbidities, 88% were ASA (American
Society of Anesthesiologists) class 3 or 4, and 81% were current or past
smokers (median pack-years = 50). Only 16% were diabetic. Serious compli-
cations occurred in 69 (11.8%) cases, of which 37 (6.3%) required arterial-
specific reinterventions. Eight patients died within 30 days, a mortality of
1.4%. Risk factors associated with increased complications included:
African-American race (odds ratio [OR] 2.8 [95% confidence interval 1.5-
5.2], P = .002), emergency surgery (OR 3.8 [2.0-7.0], P < .0001), ASA 4 (OR
1.9 [1.1-3.5], P = .04), dependent functional status (OR 2.5 [1.4-4.7], P =
.004), steroid use (OR 3.2 [1.2-8.7], P = .03), and need for intraoperative
red blood cell transfusion of any quantity (OR 6.3 [3.5-11.2], P < .0001).
Independent predictors for complications in the multivariate model were
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perative transfusion (adjusted OR 4.5 [2.3-8.9], P = .0002). Postoperative
bleeding complications within 72 hours independently predicted early ampu-
tation (adjusted OR 25.5 [1.7-393], P = .02). Unadjusted patient survival was
92.6% at one year and 86.1% at two years. Limb salvage in surviving patients
was 99.0% at 30 days, 97.6% at one year, and 96.2% at two years. Dependent
preoperative functional status was the only factor predictive of worse two-
year limb salvage (adjusted OR 4.6 [1.9-10.9], P = .001), but remained high
at 88.2% versus 97.1% in independent patients.
Conclusions: Surgical intervention for PAA is associated with low operative
mortality and offers excellent two-year limb salvage, even in high-risk patients.
Patients’ preoperative functional status and perioperative blood transfusion
requirements were the most predictive indicators of negative outcomes.
Endovascular treatment for carotid artery stenosis after neck irradiation
Jean-Pierre Favre, Alice Nourissat, Ambroise Duprey, Ghislain Nourissat,
Jean Noe¨l Albertini, Jean-Pierre Becquemin, Association Universitaire de
Recherche en Chirurgie Vasculaire
Background: To lower the risk of complications, carotid angioplasty and
stenting (CAS) has been proposed as an alternative to open surgery for
carotid artery stenosis after neck irradiation. However, there are little post-
operative data to support the benefits of this strategy. This study evaluated
the outcome of CAS in patients who had undergone neck irradiation.
Methods: This retrospective study was conducted at 15 vascular surgery or
interventional radiology centers in France between January 1998 and July
2006. A total of 135 patients (115 men) with a mean age of 67  8 years
(range, 43e88) underwent CAS for 149 irradiation-induced lesions. The
interval between irradiation and discovery of the lesions was 12  8 years.
Mean diameter reduction was 81% (range, 50%e95%), and stenosis was symp-
tomatic in 34%. Contralateral carotid lesions were observed in 48% of
patients, including thrombosis in 18 and stenosis >50% in 53.
Results: Technical failure occurred during CAS in three cases. The overall
technical success rate was 98%. A cerebral protection device was used in
59%. No death, one transient ischemic attack, and two strokes occurred
during the first postoperative month. Mean follow-up was 30 months. Six
patients were lost to follow-up. Survival rates were 93.9% at 1 year and
75.3% at 3 years. Complications after the first postoperative month included
neurologic events in six, carotid thrombosis in nine, and restenosis in 18. The
rates of freedom from neurologic and anatomic events were, respectively,
96.2% and 93.2% at 1 year and 93.1% and 85.9% at 3 years.
Conclusion: The immediate outcome of CAS for irradiation-induced carotid
artery stenosis was satisfactory. Medium-term neurologic outcome was
acceptable, but the incidence of anatomic events such as thrombosis and rest-
enosis was high. A randomized study is needed to confirm that the outcome of
the endovascular and surgical therapy is comparable in this indication.The long-term outcomes of percutaneous therapy for renal artery
fibromuscular dysplasia
Mark G. Davies, Wael E. Saad, Eric K. Peden, Imran T. Mohiuddin, Joseph J.
Naoum, Alan B. Lumsden
Background: Percutaneous intervention for symptomatic renal artery fibro-
muscular dysplasia (FMD) has replaced surgical therapy as first-line treat-
ment. This study evaluates the factors that impact long-term anatomic
and functional outcomes of endovascular therapy for symptomatic renal
artery FMD.
Methods: Records of patients who underwent renal artery angioplasty for
FMD between January 1990 and December 2007 were retrospectively
analyzed. Indication for intervention was poorly controlled hypertension
(diastolic blood pressure >90 mm Hg or systolic blood pressure >140 mm
Hg, or both, taking >2 antihypertensive medications). Twenty-nine women
(average age, 45 years [range, 18-80]; 86% with a history of hypertension
<8 years) underwent 38 attempted interventions. Sixty-six percent of
contralateral kidneys were normal (31% had a 60% stenosis), 13% had
>60% stenosis, and the remainder were nonfunctioning or absent. Creatinine
was >1.5 mg/dL in 4%, 24% had hyperlipidemia, 17% had metabolic
syndrome, and 4% were considered diabetic.
Outcomes: All interventions were successfully performed. Stent placement
was required in 13% for technical failure and flow-limiting dissection.
Seventy-three percent of these lesions were in the proximal renal artery,
with the remainder in the middle renal artery. Technical success (<30%residual stenosis) was achieved in all vessels. There were no periprocedural
or 90-day deaths. The procedurally related complication rate was 8%.
Median follow-up was 2 years. All patients were alive at follow-up. Primary
and assisted primary patency rates were 66% and 87% at 5 years. Restenosis
was considered a 50% reduction in luminal area on angiography during
follow-up. The restenosis rate was 28% at 5 years (10 vessels underwent
repeat percutaneous intervention). Immediate clinical benefit was seen in
hypertension in 72% (improved or cured 3 months) and was maintained in
73% at 5 years by life-table analysis. Proportional hazard analysis showed
the predictors of long-term clinical benefit were duration of hypertension
<8 years, creatinine <1.5 mg/dL, ipsilateral kidney size >9 cm, functional
status of the contralateral kidney, a fasting blood glucose <110 mg/dL,
triglycerides <150 mg/dL, and high-density lipoprotein >50 mg/dL. Neither
age <50 years nor statin administration appeared significant.
Conclusions: Percutaneous endovascular intervention for clinically symp-
tomatic FMD in the renal arteries is technically successful, safe, and
durable. Most patients have immediate clinical benefit, with continued
long-term results out to 5 years. It appears that the presence of existing
renal pathology and markers of prediabetic state are associated with recur-
rence of hypertensive symptoms.
Common femoral artery occlusive disease: Contemporary results
following surgical endarterectomy
Jeanwan L. Kang, Virendra I. Patel, Mark F. Conrad, Glenn M. LaMuraglia,
Thomas K. Chung, Richard P. Cambria
Objective: Proliferation of endovascular techniques with perceived reduc-
tion in treatment morbidity repetitively question the precept that surgical
endarterectomy is the preferred treatment for occlusive disease of the
common femoral artery (CFA). This study details a contemporary experience
with common femoral endarterectomy (CFE) with and without concomi-
tantly performed endovascular therapies.
Methods: Technical, hemodynamic, and clinical success of CFE performed
between 2002 and 2005 were determined according to the Society of Vascular
Surgery reporting standards. Primary and assisted patencies of the CFA
segment, freedom from reintervention in the ipsilateral limb, and survival
were assessed using Kaplan-Meier life-table analysis. Multivariate analysis
was performed to evaluate factors associated with patency and survival.
Results: CFE was performed on 65 limbs in 58 patients (mean age 71  10;
male 77%; diabetes 28%; creatinine  1.5 mg/dL 19%). Forty-four cases (68%)
were performed for claudication, and 21 cases (32%) for critical limb
ischemia. Thirty-seven cases (57%) were performed as a hybrid procedure
wherein concomitant endovascular interventions were performed. Twenty
iliac (TASC II A-30%; B-35%; C-20%; D-15%) and 25 femoropopliteal (TASC II
A-24%; B-60%; C-12%; D-4%) lesions were treated. Technical success was
achieved in 100% of the cases. Hemodynamic success was achieved in 95%
of the cases with mean postoperative increase in ankle-brachial index
(ABI) of 0.24  0.24. All but one patient (98.5%) had improvement in symp-
toms and/or ABI. Average hospital stay was 3.2 days (range 1e12 days).
There were 3 (5%) major complications requiring reintervention (early
failure secondary to untreated inflow lesion, hematoma, and wound infec-
tion), six (9%) minor complications which were treated conservatively (five
wound infections, one lymph leak), and no perioperative mortality. With
a mean follow-up period of 27 months (range 1e58 months), 1- and 5-year
primary patencies were 93% and 91%, respectively. Assisted patency was
100% at both time points. There was no difference in patencies between
CFE performed alone or as a hybrid procedure. Multivariate analysis showed
congestive heart failure (CHF) as the only predictor of primary failure (odds
ratio [OR] 18.5 [2.6-142.9]; P = .004). Freedom from reintervention in the
ipsilateral limb was 82% at 1 year and 78% at 5 years, with CHF again as
the only predictor of reintervention (OR 5.3 [1.4-19.6]; P = .012). Survival
was 89% at 1 year and 70% at 5 years. There were no amputations.
Conclusions: These data suggest CFE should remain the standard of care for
occlusive disease of the CFA. Its safety and efficacy establish a standard for
comparison with emerging endovascular therapies.Mid-term outcome after the distal revascularization and interval ligation
(DRIL) procedure
Thomas S. Huber, Michael P. Brown, James M. Seeger, W. Anthony Lee
Background: The distal revascularization and interval ligation (DRIL)
procedure has evolved as the optimal treatment for access-related hand
Abstracts 499ischemia despite concerns about its durability. This study was designed to
review our institutional experience and objectively define its mid-term
outcome.
Methods: A retrospective review of all patients undergoing the DRIL proce-
dure was performed. The diagnosis of severe hand ischemia was made based
primarily upon clinical presentation, but confirmed with noninvasive imaging
in select cases. The DRIL conduit was selected based upon noninvasive
imaging (vein conduit criteria: saphenous > arm; diameter 3 mm) and
the proximal anastomosis was positioned 7 cm from the access anasto-
mosis. The DRIL bypasses were followed in a graft surveillance protocol
and remedial procedures performed as dictated by clinical or ultrasound
scan findings.
Results: Sixty-four DRIL procedures were performed in 61 patients (age - 58
 13 standard deviation [SD], female e 62%, diabetic e 72%). The index
access procedures included: autogenous brachiocephalic e 46%, autogenous
brachiobasilic e 31%, autogenous brachioaxillary translocated femoral vein
e 20%, other e3%. The precipitating symptoms were pain (25%), paresthesia
(34%), motor dysfunction (24%), and tissue loss (17%); a pre-emptive DRIL
was performed in 5 patients. The timing of the DRIL relative to the index
access was dictated by the symptoms: <24 hrs e 19%; 1 day  DRIL 7 days
e 29%; 7 days  DRIL 30 days e 8%; >30 days e 44%. Peri-operative
mortality rate was 3% and the complication rate was 22% (wound e 14%).
The DRIL procedure relieved the ischemic symptoms in 78% of the cases
(residual symptoms: paresthesia e 13%; pain e 5%; tissue loss e 4%; motor
e 2%). The DRIL also resulted in significant (P < .05) increases in both the
wrist/brachial index (WBI) and digital/brachial index (DBI) with the mean
increases of 0.34  0.26 and 0.41  0.21, respectively. The primary DRIL
patency rates ( standard error of the mean [SEM]) were 77  8%, 74 
9%, and 71  9% at 1 year, 3 years, and 5 years, respectively, while the cor-
responding secondary patency rates were 81  7%, 76  9%, and 76  9%, and
the survival rates were 71  6%, 59  7%, and 33  9%. The index access
procedure went on to mature sufficiently for cannulation in 68% of the cases
when the DRIL was performed early (ie, <3 months from index access); all
accesses functional at the time of the DRIL were used for dialysis throughout
the peri-operative period.
Conclusion: The DRIL procedure safely and effectively relieves the symp-
toms of severe access-related hand ischemia while preserving the access.
The mid-term results suggest that the DRIL bypasses are durable,
although long-term graft surveillance may be justified given the observed
failures.Assessment of techniques to reduce sclerosant foam migration during
ultrasound-guided sclerotherapy of the great saphenous vein
Douglas Hill, Rhonda Hamilton, Tak Fung
Background: Endovenous chemical ablation is a technique for treatment of
great saphenous vein insufficiency. However, echogenic phenomena in the
right heart and high intensity transient signals detected by transcranial
Doppler have been described subsequent to foam sclerotherapy. An ischemic
event after foam sclerotherapy of the great saphenous vein was reported
recently in a patient with an occult patent foramen ovale. Another concern
is the effects of sclerosant foam on the pulmonary microvasculature.
Objective: This study is a retrospective report comparing the utility of three
commonly used techniques for reducing sclerosant foam migration during
ultrasound-guided sclerotherapy of the great saphenous vein.
Methods: Group 1 consisted of 20 patients treated with ultrasound-guided
foam sclerotherapy of the great saphenous vein while lying supine, with
digital pressure used to occlude the saphenofemoral junction. In group 2,
19 patients underwent injection while the leg was elevated 30, with digital
pressure at the saphenofemoral junction. Group 3 comprised 19 patients in-
jected while the leg was elevated but without manual compression at the
saphenofemoral junction. All patients were monitored with subcostal echo-
cardiography during the injection and for 3 to 5 minutes after.
Results: Echogenic phenomena were demonstrated in the right heart in all 20
patients in group 1, in 16 of 19 in group 2, and in nine of 19 in group 3. There was
a statistically significant difference in the incidence of echogenic phenomena
between groups 1 and 3 using the Fisher exact test (P < .001). A significant
difference in incidence was also present when groups 2 and 3 were compared
(P < .038). In groups 1 and 2, a concentrated bolus of bubbles was frequently
observed after release of digital pressure; however, less intense echogenic
phenomena were seen in group 3 where injection was performed with the
leg elevated but without manual pressure at the saphenofemoral junction.
No echogenic phenomena were observed in the left heart, and no complica-
tions occurred. Short-term treatment results wereequivalent among the three
groups.
Conclusions: Ultrasound-guided sclerotherapy of the great saphenous vein
using foam sclerosants is best performed with the leg elevated and no occlu-
sive pressure at the saphenofemoral junction in order to reduce the risk of
gas embolization to the central nervous system. Further study is needed
to assess the midterm success of this technique and to confirm the effect
of using foam produced from physiologic gases.
